DAWN - Day One Biopharmaceuticals, Inc.

QQQ $ 628.93 $ 10.99 (1.78 %)

DIA $ 475.40 $ 3.14 (0.66 %)

SPY $ 685.52 $ 7.99 (1.18 %)

TLT $ 91.88 $ 0.31 (0.34 %)

GLD $ 367.78 $ -10.51 (-2.78 %)

Previous Close

$ 7.5

Open

$ 7.58

Bid

$ 7.40 x 100

Ask

$ 7.99 x 30

Day's Range

$ 7.44 - $ 7.86

52 Week Range

$ 5.64 - $ 16.76

Volume

928,920

Average Volume

Market Cap

768.24M

Beta (5Y Monthly)

$ 0.15

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-06-2025	03-31-2025	10-Q
3	02-25-2025	12-31-2024	10-K
4	10-30-2024	09-30-2024	10-Q
5	08-02-2024	06-30-2024	10-Q
6	05-06-2024	03-31-2024	10-Q
7	02-26-2024	12-31-2023	10-K
8	11-06-2023	09-30-2023	10-Q
9	08-07-2023	06-30-2023	10-Q
10	05-01-2023	03-31-2023	10-Q
11	03-06-2023	12-31-2022	10-K
12	11-07-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-07-2022	12-31-2021	10-K
16	11-08-2021	09-30-2021	10-Q
17	08-10-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

super-micro-computer-posts-downbeat-q4-results-joins-personalis-snap-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Super Micro Computer Posts Downbeat Q4 Res...
08/06/2025 12:11:55

HC Wainwright & Co. Maintains Buy on Day O...
08/06/2025 11:24:39

HC Wainwright & Co. analyst Andrew S. Fein maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the p...

Needham Maintains Buy on Day One Biopharma...
08/06/2025 09:39:05

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target from $18 ...

why-astera-labs-shares-are-trading-higher-by-over-17-here-are-20-stocks-moving-premarket

Why Astera Labs Shares Are Trading Higher ...
08/06/2025 09:35:31

12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 21:07:20

Day One Biopharmaceutical Q2 EPS $(0.29) B...
08/05/2025 20:01:12

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimat...

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

Needham Maintains Buy on Day One Biopharma...
05/07/2025 12:19:17

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target from $30 ...

Day One Biopharmaceutical Q1 EPS $(0.35) B...
05/06/2025 20:04:54

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimat...

Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

HC Wainwright & Co. Reiterates Buy on Day ...
04/03/2025 10:43:21

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains...

Goldman Sachs Maintains Buy on Day One Bio...
03/25/2025 15:38:11

Goldman Sachs analyst Andrea Tan maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target fr...

JP Morgan Maintains Overweight on Day One ...
03/05/2025 14:57:57

JP Morgan analyst Anupam Rama maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight and lowers the price targe...

Wedbush Reiterates Outperform on Day One B...
02/26/2025 15:47:03

Wedbush analyst Robert Driscoll reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Outperform and maintains $32 price...

HC Wainwright & Co. Maintains Buy on Day O...
02/26/2025 12:26:17

HC Wainwright & Co. analyst Andres Maldonado maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the...

Needham Reiterates Buy on Day One Biopharm...
02/26/2025 11:13:45

Needham analyst Ami Fadia reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $32 price target.

Day One Biopharmaceutical Q4 GAAP EPS $(0....
02/25/2025 21:23:05

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.69) per share which missed the analyst consensus estim...

Earnings Scheduled For February 25, 2025
02/25/2025 08:32:24

Goldman Sachs Maintains Buy on Day One Bio...
02/10/2025 17:01:21

Goldman Sachs analyst Andrea Tan maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target fr...

Needham Reiterates Buy on Day One Biopharm...
01/13/2025 16:06:28

Needham analyst Ami Fadia reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $33 price target.